Concepts (258)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Magnetic Resonance Spectroscopy | 47 | 2023 | 3760 | 4.130 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 22 | 2019 | 570 | 2.760 |
Why?
|
| Creatine | 24 | 2023 | 421 | 1.680 |
Why?
|
| Aspartic Acid | 23 | 2023 | 574 | 1.480 |
Why?
|
| Inositol | 14 | 2021 | 216 | 1.480 |
Why?
|
| Choline | 22 | 2023 | 487 | 1.240 |
Why?
|
| Simian immunodeficiency virus | 14 | 2019 | 846 | 1.200 |
Why?
|
| Macaca mulatta | 26 | 2019 | 2378 | 1.070 |
Why?
|
| Gangliosidoses, GM2 | 2 | 2023 | 17 | 1.040 |
Why?
|
| Glutamic Acid | 7 | 2022 | 1167 | 0.910 |
Why?
|
| Brain | 36 | 2022 | 26343 | 0.890 |
Why?
|
| Amyotrophic Lateral Sclerosis | 6 | 2021 | 1421 | 0.870 |
Why?
|
| Magnetic Resonance Imaging | 32 | 2022 | 35342 | 0.760 |
Why?
|
| Glioblastoma | 5 | 2021 | 3456 | 0.740 |
Why?
|
| Spectrum Analysis | 2 | 2021 | 451 | 0.720 |
Why?
|
| Carbon Radioisotopes | 1 | 2018 | 592 | 0.580 |
Why?
|
| Brain Neoplasms | 8 | 2021 | 8829 | 0.580 |
Why?
|
| Minocycline | 3 | 2018 | 163 | 0.570 |
Why?
|
| Echo-Planar Imaging | 1 | 2021 | 659 | 0.570 |
Why?
|
| Acetamides | 1 | 2018 | 249 | 0.570 |
Why?
|
| Anti-Retroviral Agents | 6 | 2022 | 1712 | 0.560 |
Why?
|
| Gyrus Cinguli | 1 | 2022 | 1088 | 0.550 |
Why?
|
| Protons | 9 | 2019 | 1126 | 0.540 |
Why?
|
| Lymphocyte Depletion | 4 | 2013 | 608 | 0.520 |
Why?
|
| Brain Chemistry | 2 | 2016 | 981 | 0.500 |
Why?
|
| Brain Diseases | 3 | 2022 | 1554 | 0.470 |
Why?
|
| Biopolymers | 1 | 2013 | 189 | 0.430 |
Why?
|
| Angiogenesis Inhibitors | 2 | 2021 | 2038 | 0.410 |
Why?
|
| Cerebellar Ataxia | 2 | 2023 | 145 | 0.410 |
Why?
|
| Spinocerebellar Ataxias | 2 | 2022 | 88 | 0.410 |
Why?
|
| AIDS Dementia Complex | 5 | 2016 | 152 | 0.380 |
Why?
|
| CD8-Positive T-Lymphocytes | 9 | 2016 | 4438 | 0.380 |
Why?
|
| AIDS-Associated Nephropathy | 1 | 2010 | 35 | 0.370 |
Why?
|
| Neurons | 7 | 2018 | 9325 | 0.360 |
Why?
|
| RNA, Viral | 1 | 2018 | 2899 | 0.350 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2018 | 2231 | 0.340 |
Why?
|
| Central Nervous System | 2 | 2016 | 1354 | 0.340 |
Why?
|
| Diffusion Tensor Imaging | 2 | 2020 | 2304 | 0.330 |
Why?
|
| Positron-Emission Tomography | 4 | 2022 | 6259 | 0.320 |
Why?
|
| Adrenoleukodystrophy | 1 | 2008 | 123 | 0.290 |
Why?
|
| Neuroprotective Agents | 2 | 2010 | 941 | 0.280 |
Why?
|
| Neovascularization, Pathologic | 2 | 2016 | 2633 | 0.280 |
Why?
|
| Pyridines | 1 | 2018 | 2818 | 0.280 |
Why?
|
| Energy Metabolism | 3 | 2020 | 2896 | 0.260 |
Why?
|
| gamma-Aminobutyric Acid | 3 | 2022 | 1123 | 0.240 |
Why?
|
| Machado-Joseph Disease | 1 | 2023 | 26 | 0.240 |
Why?
|
| Ketones | 2 | 2022 | 189 | 0.240 |
Why?
|
| Image Processing, Computer-Assisted | 7 | 2020 | 8925 | 0.240 |
Why?
|
| Gliosis | 2 | 2020 | 243 | 0.230 |
Why?
|
| Disease Models, Animal | 9 | 2018 | 18006 | 0.230 |
Why?
|
| Neurodegenerative Diseases | 2 | 2023 | 1060 | 0.230 |
Why?
|
| Seizures | 1 | 2016 | 2851 | 0.220 |
Why?
|
| 3-Hydroxybutyric Acid | 1 | 2022 | 87 | 0.210 |
Why?
|
| Sandhoff Disease | 1 | 2021 | 13 | 0.200 |
Why?
|
| Tay-Sachs Disease | 1 | 2021 | 17 | 0.200 |
Why?
|
| Misonidazole | 2 | 2018 | 34 | 0.200 |
Why?
|
| Central Nervous System Diseases | 3 | 2015 | 518 | 0.190 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2021 | 9185 | 0.190 |
Why?
|
| Viral Load | 6 | 2011 | 3292 | 0.170 |
Why?
|
| Humans | 51 | 2023 | 742088 | 0.170 |
Why?
|
| Thalamus | 2 | 2023 | 1023 | 0.170 |
Why?
|
| Male | 33 | 2022 | 349538 | 0.160 |
Why?
|
| Motor Neurons | 3 | 2021 | 851 | 0.160 |
Why?
|
| Leukoencephalopathies | 1 | 2020 | 238 | 0.150 |
Why?
|
| Post-Concussion Syndrome | 1 | 2020 | 217 | 0.150 |
Why?
|
| Epilepsy | 1 | 2013 | 3301 | 0.150 |
Why?
|
| Research Report | 1 | 2021 | 355 | 0.150 |
Why?
|
| Glial Fibrillary Acidic Protein | 2 | 2011 | 524 | 0.150 |
Why?
|
| Rheumatic Diseases | 1 | 2023 | 590 | 0.140 |
Why?
|
| Fibromyalgia | 1 | 2021 | 388 | 0.140 |
Why?
|
| Glutarates | 1 | 2018 | 236 | 0.140 |
Why?
|
| Synaptophysin | 3 | 2011 | 141 | 0.140 |
Why?
|
| Glutamine | 2 | 2017 | 574 | 0.140 |
Why?
|
| Parietal Lobe | 1 | 2021 | 837 | 0.140 |
Why?
|
| Longitudinal Studies | 3 | 2021 | 13921 | 0.130 |
Why?
|
| Middle Aged | 19 | 2022 | 213127 | 0.130 |
Why?
|
| Treatment Failure | 1 | 2021 | 2615 | 0.130 |
Why?
|
| Lasers | 1 | 2019 | 952 | 0.130 |
Why?
|
| Metformin | 1 | 2022 | 829 | 0.130 |
Why?
|
| Biological Factors | 1 | 2016 | 164 | 0.130 |
Why?
|
| Female | 28 | 2022 | 379592 | 0.130 |
Why?
|
| Imaging, Three-Dimensional | 5 | 2018 | 4029 | 0.130 |
Why?
|
| Integrin alpha4 | 1 | 2014 | 92 | 0.120 |
Why?
|
| Low Back Pain | 1 | 2023 | 955 | 0.120 |
Why?
|
| Consensus | 2 | 2021 | 2935 | 0.120 |
Why?
|
| Vision, Binocular | 1 | 2015 | 213 | 0.120 |
Why?
|
| Microglia | 3 | 2011 | 1261 | 0.120 |
Why?
|
| Cerebellum | 1 | 2021 | 1490 | 0.120 |
Why?
|
| Animals | 27 | 2019 | 168561 | 0.110 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2014 | 349 | 0.110 |
Why?
|
| Basal Ganglia | 1 | 2016 | 545 | 0.110 |
Why?
|
| Signal Processing, Computer-Assisted | 3 | 2010 | 1538 | 0.110 |
Why?
|
| Adult | 16 | 2022 | 213712 | 0.110 |
Why?
|
| Glucose | 2 | 2022 | 4391 | 0.110 |
Why?
|
| Brain Mapping | 5 | 2019 | 6669 | 0.110 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2018 | 870 | 0.110 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2013 | 11472 | 0.110 |
Why?
|
| Ephrin-B3 | 1 | 2011 | 12 | 0.100 |
Why?
|
| GAP-43 Protein | 1 | 2011 | 152 | 0.100 |
Why?
|
| Aged | 14 | 2022 | 162944 | 0.100 |
Why?
|
| Monocytes | 3 | 2014 | 2593 | 0.100 |
Why?
|
| Ataxia | 2 | 2023 | 304 | 0.100 |
Why?
|
| Monkey Diseases | 1 | 2011 | 77 | 0.100 |
Why?
|
| Pyramidal Tracts | 1 | 2013 | 257 | 0.100 |
Why?
|
| Prognosis | 3 | 2018 | 29010 | 0.100 |
Why?
|
| Radiopharmaceuticals | 2 | 2018 | 2658 | 0.100 |
Why?
|
| Encephalitis, Viral | 1 | 2011 | 55 | 0.100 |
Why?
|
| Osteoarthritis, Knee | 1 | 2021 | 1222 | 0.090 |
Why?
|
| Cytoprotection | 1 | 2011 | 210 | 0.090 |
Why?
|
| ROC Curve | 1 | 2018 | 3528 | 0.090 |
Why?
|
| Flow Cytometry | 2 | 2011 | 5975 | 0.090 |
Why?
|
| Dacarbazine | 1 | 2013 | 567 | 0.090 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2021 | 1457 | 0.090 |
Why?
|
| Feasibility Studies | 3 | 2020 | 5062 | 0.090 |
Why?
|
| Camptothecin | 1 | 2013 | 572 | 0.090 |
Why?
|
| Macaca | 1 | 2011 | 440 | 0.090 |
Why?
|
| Motor Cortex | 1 | 2017 | 984 | 0.090 |
Why?
|
| Metabolic Diseases | 1 | 2016 | 657 | 0.080 |
Why?
|
| Psychotic Disorders | 1 | 2023 | 3040 | 0.080 |
Why?
|
| Algorithms | 4 | 2022 | 13853 | 0.080 |
Why?
|
| Transducers | 1 | 2010 | 252 | 0.080 |
Why?
|
| Gastrointestinal Tract | 1 | 2014 | 814 | 0.080 |
Why?
|
| Atrophy | 2 | 2023 | 1576 | 0.080 |
Why?
|
| Periaqueductal Gray | 1 | 2008 | 107 | 0.080 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2011 | 1086 | 0.080 |
Why?
|
| Nerve Net | 1 | 2020 | 2174 | 0.080 |
Why?
|
| Visual Cortex | 1 | 2015 | 1149 | 0.080 |
Why?
|
| Feeding Behavior | 1 | 2020 | 3187 | 0.080 |
Why?
|
| Analysis of Variance | 3 | 2011 | 6365 | 0.070 |
Why?
|
| Immunohistochemistry | 2 | 2011 | 11363 | 0.070 |
Why?
|
| Enzyme Inhibitors | 1 | 2018 | 3800 | 0.070 |
Why?
|
| Predictive Value of Tests | 2 | 2021 | 15056 | 0.070 |
Why?
|
| Autistic Disorder | 1 | 2015 | 1174 | 0.070 |
Why?
|
| Young Adult | 6 | 2021 | 56350 | 0.070 |
Why?
|
| Image Enhancement | 3 | 2016 | 2921 | 0.070 |
Why?
|
| Automation | 1 | 2008 | 584 | 0.070 |
Why?
|
| Prospective Studies | 4 | 2021 | 53187 | 0.070 |
Why?
|
| Microfilament Proteins | 1 | 2011 | 1152 | 0.070 |
Why?
|
| Tissue Extracts | 1 | 2005 | 135 | 0.060 |
Why?
|
| Disease Management | 1 | 2016 | 2450 | 0.060 |
Why?
|
| Encephalitis | 1 | 2008 | 423 | 0.060 |
Why?
|
| Aging | 2 | 2022 | 8626 | 0.060 |
Why?
|
| Spinal Cord | 1 | 2013 | 1807 | 0.060 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2007 | 363 | 0.060 |
Why?
|
| Quinazolines | 1 | 2011 | 1355 | 0.060 |
Why?
|
| Neuroimmunomodulation | 1 | 2006 | 152 | 0.060 |
Why?
|
| Child | 4 | 2023 | 77478 | 0.060 |
Why?
|
| Cohort Studies | 2 | 2021 | 40450 | 0.060 |
Why?
|
| Astrocytes | 1 | 2011 | 1266 | 0.060 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2016 | 4379 | 0.060 |
Why?
|
| Glioma | 1 | 2018 | 3388 | 0.060 |
Why?
|
| Reproducibility of Results | 5 | 2022 | 19862 | 0.060 |
Why?
|
| HIV Infections | 2 | 2022 | 16678 | 0.050 |
Why?
|
| Administration, Oral | 1 | 2010 | 3913 | 0.050 |
Why?
|
| Statistics, Nonparametric | 1 | 2008 | 2885 | 0.050 |
Why?
|
| Heterozygote | 1 | 2008 | 2790 | 0.050 |
Why?
|
| Pandemics | 1 | 2022 | 8328 | 0.050 |
Why?
|
| Metabolomics | 1 | 2010 | 1467 | 0.050 |
Why?
|
| Disability Evaluation | 1 | 2008 | 1827 | 0.050 |
Why?
|
| Diagnosis, Differential | 1 | 2016 | 12958 | 0.050 |
Why?
|
| Fatty Acids | 1 | 2008 | 1806 | 0.050 |
Why?
|
| Survival Rate | 2 | 2013 | 12773 | 0.050 |
Why?
|
| Cerebral Cortex | 2 | 2015 | 5705 | 0.050 |
Why?
|
| Receptors, GABA | 1 | 2022 | 288 | 0.050 |
Why?
|
| Severity of Illness Index | 3 | 2020 | 15530 | 0.040 |
Why?
|
| Lipids | 1 | 2010 | 3302 | 0.040 |
Why?
|
| Radio Waves | 1 | 2019 | 251 | 0.040 |
Why?
|
| Expert Testimony | 1 | 2021 | 356 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2022 | 11695 | 0.040 |
Why?
|
| Disease Progression | 3 | 2023 | 13256 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2010 | 10943 | 0.040 |
Why?
|
| Phantoms, Imaging | 2 | 2019 | 2466 | 0.040 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2006 | 1872 | 0.040 |
Why?
|
| Biological Specimen Banks | 1 | 2022 | 707 | 0.040 |
Why?
|
| Anisotropy | 1 | 2020 | 1265 | 0.040 |
Why?
|
| Child, Preschool | 2 | 2016 | 40955 | 0.040 |
Why?
|
| Macrophages | 4 | 2014 | 5655 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 2 | 2011 | 9274 | 0.030 |
Why?
|
| Reference Standards | 1 | 2019 | 1020 | 0.030 |
Why?
|
| Placebos | 1 | 2020 | 1677 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2016 | 25575 | 0.030 |
Why?
|
| Diagnostic Imaging | 1 | 2010 | 3507 | 0.030 |
Why?
|
| Communicable Disease Control | 1 | 2022 | 854 | 0.030 |
Why?
|
| Synaptic Transmission | 2 | 2015 | 1179 | 0.030 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2008 | 3328 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2018 | 13655 | 0.030 |
Why?
|
| Sex Factors | 1 | 2008 | 10392 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2010 | 4933 | 0.030 |
Why?
|
| Central Nervous System Infections | 1 | 2014 | 56 | 0.030 |
Why?
|
| Adolescent | 3 | 2020 | 85649 | 0.030 |
Why?
|
| Cell Count | 2 | 2011 | 1831 | 0.030 |
Why?
|
| Creatinine | 1 | 2019 | 1916 | 0.030 |
Why?
|
| Lymphocyte Count | 1 | 2016 | 792 | 0.030 |
Why?
|
| Infant | 1 | 2016 | 35070 | 0.030 |
Why?
|
| Activities of Daily Living | 1 | 2022 | 2414 | 0.030 |
Why?
|
| Brain Ischemia | 1 | 2007 | 3258 | 0.030 |
Why?
|
| Adaptation, Physiological | 1 | 2020 | 1310 | 0.030 |
Why?
|
| Metabolome | 1 | 2019 | 881 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2010 | 9639 | 0.030 |
Why?
|
| Virus Replication | 2 | 2011 | 2531 | 0.030 |
Why?
|
| Aged, 80 and over | 4 | 2022 | 57683 | 0.030 |
Why?
|
| Temperature | 1 | 2019 | 2207 | 0.030 |
Why?
|
| Cross-Sectional Studies | 2 | 2023 | 24913 | 0.030 |
Why?
|
| Drug Monitoring | 1 | 2018 | 956 | 0.030 |
Why?
|
| Spin Labels | 1 | 2013 | 332 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2013 | 39004 | 0.020 |
Why?
|
| Phenotype | 1 | 2008 | 16331 | 0.020 |
Why?
|
| Cerebrospinal Fluid | 1 | 2013 | 534 | 0.020 |
Why?
|
| Acute Disease | 3 | 2007 | 7141 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2016 | 77098 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 2016 | 1459 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2018 | 4929 | 0.020 |
Why?
|
| Gene Products, gag | 1 | 2010 | 337 | 0.020 |
Why?
|
| Neural Pathways | 1 | 2020 | 2971 | 0.020 |
Why?
|
| Linear Models | 2 | 2011 | 5948 | 0.020 |
Why?
|
| Lymphoid Tissue | 1 | 2010 | 455 | 0.020 |
Why?
|
| Frontal Lobe | 2 | 2005 | 1407 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2021 | 8297 | 0.020 |
Why?
|
| Receptors, IgG | 1 | 2011 | 582 | 0.020 |
Why?
|
| Equipment Failure Analysis | 1 | 2010 | 867 | 0.020 |
Why?
|
| Prostatic Neoplasms | 1 | 2010 | 11039 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2010 | 939 | 0.020 |
Why?
|
| Software | 1 | 2021 | 4434 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2020 | 12017 | 0.020 |
Why?
|
| Insulin Resistance | 1 | 2020 | 3861 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2019 | 6191 | 0.020 |
Why?
|
| Factor Analysis, Statistical | 1 | 2008 | 975 | 0.020 |
Why?
|
| Dementia | 1 | 2020 | 2501 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2016 | 6891 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 2009 | 2335 | 0.020 |
Why?
|
| Insulin | 1 | 2020 | 6575 | 0.020 |
Why?
|
| Gene Expression | 1 | 2018 | 7790 | 0.020 |
Why?
|
| Stroke | 1 | 2007 | 9963 | 0.020 |
Why?
|
| Hydrogen | 1 | 2005 | 164 | 0.020 |
Why?
|
| Glycine | 1 | 2008 | 671 | 0.020 |
Why?
|
| Models, Animal | 1 | 2011 | 2170 | 0.010 |
Why?
|
| Sensitivity and Specificity | 2 | 2010 | 14720 | 0.010 |
Why?
|
| Neuronal Plasticity | 1 | 2011 | 1418 | 0.010 |
Why?
|
| Cell Movement | 1 | 2014 | 5212 | 0.010 |
Why?
|
| Cognition | 1 | 2020 | 6722 | 0.010 |
Why?
|
| Lactic Acid | 1 | 2007 | 1132 | 0.010 |
Why?
|
| Equipment Design | 1 | 2010 | 3582 | 0.010 |
Why?
|
| Prostate | 1 | 2010 | 1764 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2011 | 3199 | 0.010 |
Why?
|
| Viremia | 1 | 2004 | 735 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 2011 | 3465 | 0.010 |
Why?
|
| Inflammation | 1 | 2019 | 10578 | 0.010 |
Why?
|
| Hippocampus | 1 | 2011 | 3661 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2010 | 4414 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2005 | 2372 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2015 | 21719 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2011 | 13029 | 0.010 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2007 | 2736 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2011 | 10472 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2005 | 6483 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2020 | 62966 | 0.010 |
Why?
|
| Mutation | 1 | 2018 | 29717 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2004 | 9144 | 0.010 |
Why?
|
Concepts
(258)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(88)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_